Publication

Article

Family Practice Recertification

May 2015
Volume33
Issue 5

Q&A With William Tierney From Regenstrief Institute: Regenstrief Institute Looks at Patient Concerns for Electronic Health Records

Author(s):

Having one of the oldest electronic health record systems in the country the state of Indiana has been at the forefront of the field for close to 30 years. Using those records and networks in the state a group from the Regenstrief Institute looked at how patients might want to control who can see their records.

Having one of the oldest electronic health record systems in the country the state of Indiana has been at the forefront of the field for close to 30 years. Using those records and networks in the state a group from the Regenstrief Institute looked at how patients might want to control who can see their records.

William M. Tierney, MD, President and CEO of the Regenstrief Institute and a professor at Indiana University discussed how the team was able to use existing technology to adapt to the task they were given. As a result of "tinkering," with the program, Tierney said patients were able to decide whether they wanted all their records, none of their records, or some of their records made available to their healthcare professionals.

Related Videos
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
© 2024 MJH Life Sciences

All rights reserved.